CIRS Group
Medical Devices
C&K Testing
Carbon Neutrality

CIRS Korea Submitted Applications for Pre-registration

from CIRS by

1 Jan. 2019, K-REACH pre-registration officially initiated. Enterprises may submit pre-registration through REACH-IT. As an only representative (OR), CIRS Group Korea Co., Ltd. successfully submitted applications for pre-registration on behalf of overseas enterprises.

In accordance with the requirements of the amended K-REACH, enterprises shall submit applications for pre-registration of existing substances (excluding substances listed in the first batch of registration list) between 1 Jan. 2019 and 30 Jun. 2019, so as to obtain a registration grace period. Enterprises obtaining the pre-registration number can legally trade with Korean enterprises within the grace period. If related enterprises fail to complete pre-registration, they are not allowed to continue to manufacture/import the substances from 1 Jul. 2019. Compared with registration, K-REACH pre-registration has shorter registration period and requires lower expenses, which largely reduce enterprises’ cost. CIRS warmly suggests that related enterprises should complete pre-registration.

Overseas manufacturers shall entrust an OR to fulfill the obligations under K-REACH. In order to help enterprises comply with the K-REACH regulation, CIRS Group Korea Co., Ltd. was established. CIRS Group Korea has a team of K-REACH experts that have over ten years of TCCA and K-REACH regulatory compliance experience. It is certain that CIRS Group Korea will provide professional services to related enterprises.

If you have any needs or questions, please contact us at


We have launched a LinkedIn newsletter to keep you up to date on the latest developments across the chemical industry including food and FCMs and personal and home care.